Rare Cancer Research And Prevention Highlighted At Japan Cancer Research Council Meeting
This article was originally published in PharmAsia News
Opinions from Japanese patient groups, academic organizations, and the pharmaceutical industry were heard regarding new strategies for cancer research at the second annual meeting of “Experts regarding the Future of Cancer Research” held on April 23.
You may also be interested in...
The race is now on to get formal adoption of European Commission proposal postponing the MDR by one year and allowing more devices on the market more quickly. But potential hurdles are in the way as experts advise caution.
Australia’s competition regulator, the ACCC, has granted a conditional dispensation to allow generics industry association the GBMA and brand body Medicines Australia to work together to help address the coronavirus pandemic by sharing information on stock, inventory, manufacturing and the supply chain. However, tender pricing will not be among the subjects discussed.